Tumor control probability (TCP) and normal tissue complication probability (NTCP) in head and neck cancer

Rays - International Journal of Radiological Sciences

Volumn 30, Issue 2, 2005, Pages 105-108

  Grégoire, Vincent ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

Head neck cancer; TCP NTCP EUD

Indexed keywords

CONCEPT FORMATION; DIABETES MELLITUS; DISEASE ASSOCIATION; DOSE RESPONSE; GENETIC DISORDER; HEAD AND NECK CANCER; HUMAN; HYPERTENSION; NORMAL TISSUE COMPLICATION PROBABILITY; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIOBIOLOGY; REVIEW; RISK FACTOR; STATISTICAL MODEL; TIME; TREATMENT PLANNING; TUMOR CONTROL PROBABILITY;

COMORBIDITY; DOSE FRACTIONATION; DOSE-RESPONSE RELATIONSHIP, RADIATION; HEAD AND NECK NEOPLASMS; HUMANS; PROBABILITY; RADIATION TOLERANCE; RADIOTHERAPY DOSAGE; RADIOTHERAPY, CONFORMAL;

EID: 27744472782     PISSN: 03907740     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (12)

1. BENTZEN SM. Dose-response relationships in radiotherapy. In: Steel GG ed. Basic clinical radiobiology. Arnold, London, 2002, 94-104.
2. BENTZEN SM. Radiobiological considerations in the design of clinical trials. Radiother Oncol 1994; 32: 1-11.
3. LYMAN JT. Complication probability as assessed from dose-volume histograms. Radiat Res Suppl. 1985; 8: S13-9.
4. RUBIN P. Law and order of radiation sensitivity. Absolute versus relative. Front Radiat Ther Oncol 1989; 23: 7-40.
5. EISBRUCH A, TEN HAKEN RK, KIM HM, MARSH LH, SHIP JA. Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer. Int J Radiat Oncol Biol Phys 1999; 45: 577-587.
6. CHAO KS, DEASY JO, MARKMAN J et al. A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: initial results. Int J Radiat Oncol Biol Phys 2001; 49: 907-916.
7. MAES A, WELTENS C, FLAMEN P et al. Preservation of parotid function with uncomplicated conformal radiotherapy. Radiother Oncol 2002; 63: 203-211.
8. BUSSELS B, MAES A, FLAMEN P et al. Dose-response relationships within the parotid gland after radiotherapy for head and neck cancer. Radiother Oncol 2004; 73: 297-306.
9. SAARILAHTI K, KOURI M, COLLAN J et al. Intensity modulated radiotherapy for head and neck cancer: evidence for preserved salivary gland function. Radiother Oncol 2005; 74: 251-258.
10. HONORE HB, BENTZEN SM, MOLLER K, GRAU C. Sensori-neural hearing loss after radiotherapy for nasopharyngeal carcinoma: individualized risk estimation. Radiother Oncol 2002; 65: 9-16.
11. NIEMIERKO A. Reporting and analyzing dose distributions: a concept of equivalent uniform dose. Med Phys 1997; 24: 103-110.
12. Wu Q, MOHAN R, NIEMIERKO A et al. Optimization of intensity-modulated radiotherapy plans based on the equivalent uniform dose. Int J Radiat Oncol Biol Phys 2002; 52: 224-235.